Testing for cannabis is making it increasingly harder for maritime companies to hire employees . Pre-employment drug tests have been a staple in the ...

Aurora Cannabis Inc. closed 54.01% short of its 52-week high of $9.35, which the company achieved on April 30th.

Shares of Aurora Cannabis Inc. ACB rose 1.62% to $4.40 Wednesday, on what proved to be an all-around mixed trading session ...

Has Aurora Cannabis Inc. (ACB) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer ...

Aurora Cannabis has transformed its margins, market position, and balance sheet over the last few years, and the stock is now highly 'investible'. ACB's strategic focus on the global medical ...

Canadian cannabis stock Aurora Cannabis (TSE:ACB) is stepping up its line of offerings in Australia, and bringing a new set of pastille products for customers down there. The news will prove ...

Detailed price information for Aurora Cannabis Inc (ACB-T) from The Globe and Mail including charting and trades.

Shares of Aurora Cannabis Inc. (ACB) have gained 50.8% over the past four weeks to close the last trading session at $5.61, but there could still be a solid upside left in the stock if short-term ...

Aurora Cannabis (ACB) has announced today the company’s extended pastille offerings in Australia. This expansion marks another meaningful step in Aurora’s deep commitment to offering patients ...

Aurora Cannabis Inc. (TSE:ACB – Get Free Report) has earned an average recommendation of “Moderate Buy” from the five brokerages that are currently covering the company, MarketBeat.com reports.